Published online Sep 15, 2000. doi: 10.3748/wjg.v6.iSuppl3.53
Revised: June 16, 2000
Accepted: July 10, 2000
Published online: September 15, 2000
AIM: To study the changes of interleukin(IL)-6, IL-2, sIL-2R and TNF in patients with hepatocellular carcinoma(HCC)and their clinical significance.
METHODS: IL-6, IL-2, sIL-2R and TNF were detected by avidin-biotin-system enzyme linked immunosorbent assay (ELISA), double-sandwich ELISA respectively in 60 patients with HCC and 36 patients with liver cirrhosis (LC) and 66 healthy persons.
RESULTS: The levels of IL-6, sIL-2R and TNF increased, but IL-2 level was lower in patients with HCC than that in normal controls (NC) (t test, t = 8.21, 4.71, 3.87, 2.13, P < 0.01 or 0.05). IL-6 level in HCC was 10 fold higher than NC, and also much higher than LC. IL-6 level was higher in later stage than that in earlier stage. There was a positive correlation between IL-6 and sIL-2R, TNF, while no positive correlation was found between IL-2 and IL-6, sIL-2R in HCC.
CONCLUSION: The remarkably higher level of IL-6 is helpful for the early diagnosis of HCC.
- Citation: Zhao CY, Li YL, Liu SX, Feng ZJ. Changes of IL-6 and relevant cytokines in patients with hepatocellular carcinoma and their clinical significance. World J Gastroenterol 2000; 6(Suppl3): 53-53
- URL: https://www.wjgnet.com/1007-9327/full/v6/iSuppl3/53.htm
- DOI: https://dx.doi.org/10.3748/wjg.v6.iSuppl3.53
E- Editor: Zhang FF